Form 4: Executive Chairman Krantz Acquires Definitive Healthcare RSUs

Definitive Healthcare's Executive Chairman, Jason Ronald Krantz, acquired 242,719 restricted stock units set to vest in March 2027.

Summary

• Jason Ronald Krantz, Executive Chairman, Director, and 10% Owner of Definitive Healthcare Corp. (DH), acquired 242,719 shares of Class A Common Stock.
• These shares are Restricted Stock Units (RSUs) with a transaction date of February 24, 2026.
• The RSUs will vest 100% on March 1, 2027, contingent on Mr. Krantz's continued service with the Issuer.
• The acquisition price for these RSUs was $0, which is typical for equity compensation grants.
• Following this transaction, Mr. Krantz directly beneficially owns 1,258,758 shares and indirectly owns 450,000 shares through DH Holdings (f/k/a Jason R. Krantz 2009 Trust).
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this RSU grant as a positive sign of continued executive commitment and alignment with long-term shareholder interests, typical for executive compensation.

Positives

• Executive Chairman Jason Ronald Krantz acquired a significant number of Restricted Stock Units (242,719), indicating continued commitment to the company.
• The vesting schedule (100% on March 1, 2027) aligns management's long-term interests with shareholder value.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned equity compensation event.

Risks

• The vesting of the RSUs is subject to Mr. Krantz's continued service with the Issuer, meaning the shares could be forfeited if he departs before March 1, 2027.

Future Outlook

The grant of Restricted Stock Units with a future vesting date of March 1, 2027, indicates an expectation of continued service from Executive Chairman Jason Ronald Krantz and aligns his future incentives with the company's long-term performance.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the healthcare technology sector, designed to retain key talent and align management incentives with long-term shareholder value. This grant to a key executive like Mr. Krantz is consistent with industry practices for retaining leadership.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to an Executive Chairman is a standard practice in the technology and healthcare sectors for executive compensation, similar to grants observed at companies like Veeva Systems or IQVIA, which also utilize equity awards to incentivize long-term performance and retention.
• The vesting schedule, contingent on continued service, is typical for such awards, ensuring that executive interests remain aligned with the company's sustained success, mirroring structures seen in compensation packages across the S&P 500.

Related Party Transactions

• Jason Ronald Krantz's indirect beneficial ownership of 450,000 shares is held in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary, representing a related party holding.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Executive Chairman's long-term interests with shareholder value, potentially fostering sustained growth.
• Employees: Demonstrates continued stability in executive leadership, which can positively impact employee morale and strategic direction.

Next Steps

• Continued service of Jason Ronald Krantz with Definitive Healthcare Corp. until March 1, 2027, for the RSUs to fully vest.

Key Dates

Recommendation

This Form 4 filing reports a routine RSU grant to an executive, which is a standard compensation practice and indicates continued commitment. It does not present new information that would fundamentally alter the investment thesis for Definitive Healthcare Corp., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Definitive Healthcare, DH, Jason Ronald Krantz, Form 4, Restricted Stock Units, RSU, Insider Ownership, Executive Compensation, Equity Grant, 10b5-1 Plan